The FDA on Friday recommended new guidelines that would let drug and medical-device makers supply doctors with copies of journal articles on off-label uses of their products. Advocates say the proposal would give physicians access to credible scientific data that could potentially save lives, while critics argue that allowing such a practice could compromise patient safety and result in unreliable research on the benefits of drugs and devices.

Full Story:

Related Summaries